RIO DE JANEIRO, BRAZIL - China's National Health Commission has recommended the use of chloroquine in the treatment of Covid-19 patients, reports the South China Morning Post. In its first update of its "treatment guidelines" since March, the body cautions:
"Some drugs may demonstrate a certain degree of efficacy for treatment in clinical observation trials, but there are no effective antiviral drugs confirmed by double-blind, placebo-controlled clinical trials."
In addition to chloroquine, "other recommended antiviral drugs include Interferon and Arbidol, but Ribavirin should be used in combination with Lopinavir or Ritonavir," the committee published.
According to the . . .